Vigil Neuroscience, Inc. (VIGL) Dividend History

Company News

• Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

  Sanofi has completed its acquisition of Vigil Neuroscience for $470 million, gaining a novel TREM2 agonist (VG-3927) for potential Alzheimer's disease treatment and strengthening its neurology research pipeline.

  GlobeNewswire Inc.
• $HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - PRA, AXL, SWTX and VIGL

  The M&A Class Action Firm is investigating the proposed mergers of ProAssurance Corporation, American Axle & Manufacturing Holdings, SpringWorks Therapeutics, and Vigil Neuroscience.

  Benzinga

  Featured Companies: AXL PRA SWTX
• Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

  Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).

  Zacks Investment Research

  Featured Companies: APDN BDSX PHR YOU
• The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

  A more selective small-cap index has consistently outperformed the Russell 2000

  MarketWatch

  Featured Companies: ACRV ALLO ARLO ATNM CMPX CPRX CRBU DGII DVAX GPRE HLX IJR INZY IPSC IRWD IWM KPTI LCTX LGND MODV PAYO PCRX PRVA PTEN RCUS RLYB RNA SMTC SPY STOK TALO THRY TNYA TRVI VIR VOR XFOR XNCR XPER
• New Year, Fresh Stocks: 3 IPOs That Joined the Market in January

  Should you add these stocks to your portfolio?

  The Motley Fool

  Featured Companies: AMLX AMZN